Evidence map›Paper›PMID 26930549›Full record

ArticlePhysics in medicine and biology2016

A risk index for pediatric patients undergoing diagnostic imaging with (99m)Tc-dimercaptosuccinic acid that accounts for body habitus.

Shannon E O'Reilly, Donika Plyku, George Sgouros, Frederic H Fahey, S Ted Treves, Eric C Frey, Wesley E Bolch

3 registry-linked trialsAbstract read
In one paragraph

Article in Physics in medicine and biology, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 15 papers.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed
1.4field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03107195 completednot on this mapstarted 2017, after this paper: background citation

Biokinetics Study of Tc-99m DMSA for Dose Reduction in Pediatric Molecular Imaging

TypeobservationalSponsorBoston Children's HospitalRan2017 to 2021Enrolled24ConditionsRenal DiseaseArmsImaging Time
NCT03107247 completednot on this mapstarted 2017, after this paper: background citation

Biokinetics Study for Tc-99m MDP for Dose Reduction in Pediatric Molecular Imaging

TypeobservationalSponsorBoston Children's HospitalRan2017 to 2021Enrolled12ConditionsSkeletal InjuryArmsImaging Time
NCT03107325 phase4withdrawnnot on this mapstarted 2019, after this paper: background citation

Biokinetics Study for F-18 FDG for Dose Reduction in Pediatric Molecular Imaging

TypeinterventionalSponsorBoston Children's HospitalRan2019 to 2020Enrolled0ConditionsChildhood NeoplasmArmsModification in acquisition protocol, F-18 Fluorodeoxyglucose
3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 24 citations in OpenAlex.

  1. MIRD Pamphlet No. 34, Part 1: MIRDct-A Customizable Software Tool for CT Dosimetry.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2026
    Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. MIRD Pamphlet No. 28, Part 1: MIRDcalc-A Software Tool for Medical Internal Radiation Dosimetry.Journal of nuclear medicine : official publication, Society of Nuclear Medicine · 2023
    Article
  7. Article
  8. RenalEJNMMI physics · 2021
    Article
  9. Article
  10. Investigating Low-Dose Image Quality in Whole-Body PediatricJournal of nuclear medicine : official publication, Society of Nuclear Medicine · 2021
    Article
  11. Article
  12. Article
  13. Article
  14. Use of Monte Carlo Techniques in Nuclear Medicine.Journal of the American College of Radiology : JACR · 2018
    Article
  15. Dose Estimation in Pediatric Nuclear Medicine.Seminars in nuclear medicine · 2017
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Shannon E O'ReillyJ. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611, USA.
Donika PlykuThe Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
George SgourosThe Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Frederic H FaheyDivision of Nuclear Medicine and Molecular Imaging, Boston Children's Hospital, Boston, MA 02115, USA.
S Ted TrevesDivision of Nuclear Medicine and Molecular imaging, Department of Radiology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Eric C FreyThe Russell H. Morgan Department of Radiology and Radiological Sciences, Johns Hopkins University, School of Medicine, Baltimore, MD 21205, USA.
Wesley E BolchAdvanced Laboratory for Radiation Dosimetry Studies (ALRADS), J. Crayton Pruitt Family Department of Biomedical Engineering, University of Florida, Gainesville, FL 32611-6131, USA.
Johns Hopkins University · USUniversity of Florida · USBoston Children's Hospital · USBrigham and Women's Hospital · US

Funding

Dose-Response in Radionuclide TherapyR01CA116477 · NCI · JOHNS HOPKINS UNIVERSITY · PI HOBBS, ROBERT FRANCOIS, SGOUROS, GEORGE · 2006 to 2022
$7.1M
Dose Reduction in Pediatric Molecular ImagingR01EB013558 · NIBIB · JOHNS HOPKINS UNIVERSITY · PI FREY, ERIC C., SGOUROS, GEORGE · 2012 to 2020
$4.6M
NCI NIH HHS R01 CA116477NIBIB NIH HHS R01 EB013558
6 · The paper itself

Abstract

Published guidelines for administered activity to pediatric patients undergoing diagnostic nuclear medicine imaging are currently obtained through expert consensus of the minimum values as a function of body weight as required to yield diagnostic quality images. We have previously shown that consideration of body habitus is also important in obtaining diagnostic quality images at the lowest administered activity. The objective of this study was to create a series of computational phantoms that realistically portray the anatomy of the pediatric patient population which can be used to develop and validate techniques to minimize radiation dose while maintaining adequate image quality. To achieve this objective, we have defined an imaging risk index that may be used in future studies to develop pediatric patient dosing guidelines. A population of 48 hybrid phantoms consisting of non-uniform B-spline surfaces and polygon meshes was generated. The representative ages included the newborn, 1 year, 5 year, 10 year and 15 year male and female. For each age, the phantoms were modeled at their 10th, 50th, and 90th height percentile each at a constant 50th weight percentile. To test the impact of kidney size, the newborn phantoms were modeled with the following three kidney volumes: -15%, average, and +15%. To illustrate the impact of different morphologies on dose optimization, we calculated the effective dose for each phantom using weight-based (99m)Tc-DMSA activity administration. For a given patient weight, body habitus had a considerable effect on effective dose. Substantial variations were observed in the risk index between the 10th and 90th percentile height phantoms from the 50th percentile phantoms for a given age, with the greatest difference being 18%. There was a dependence found between kidney size and risk of radiation induced kidney cancer, with the highest risk indices observed in newborns with the smallest kidneys. Overall, the phantoms and techniques in this study can be used to provide data to refine dosing guidelines for pediatric nuclear imaging studies while taking into account the effects on both radiation dose and image quality.

Indexed as

Body WeightChildChild, PreschoolFemaleHumansInfantInfant, NewbornMaleNeoplasms, Radiation-InducedPositron-Emission TomographyRadiopharmaceuticalsRiskTechnetium Tc 99m Dimercaptosuccinic AcidRadiopharmaceuticalsTechnetium Tc 99m Dimercaptosuccinic Acid

Identifiers

PMID26930549
PMCPMC5736793
OpenAlexW2289761713

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.